Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Extra Strength Tylenol "doctors recommend" claim too "all-encompassing," NAD says.

This article was originally published in The Tan Sheet

Executive Summary

McNEIL EXTRA STRENGTH TYLENOL "DOCTORS RECOMMEND" AD CLAIM is too broad and should be modified in future advertising, the National Advertising Division of the Council of Better Business Bureaus recommended in a March 5 Case Report. The watchdog agency took issue with the "all-encompassing quality" of McNeil's claim that doctors recommend Extra Strength Tylenol more than aspirin and ibuprofen for types of pain "from post-surgical pain to headaches." The television ads, created by Saatchi & Saatchi, New York, were brought before NAD by Advil maker American Home Products.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS084856

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel